文献速递肾移植

肾移植后低磷血症与死亡删失移植失败及死亡风险

Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-05-25

该纵向队列研究纳入957例1993至2008年单中心肾移植受者,分析移植后第一年最低血磷水平与长期结局的关系。中位随访9年,181例(19%)发生移植失败,295例(35%)死亡。校正后,血磷每降低1 mg/dl,死亡删失移植失败风险降低(HR 0.61,95%CI 0.43-0.88),心血管死亡风险降低(HR 0.37,95%CI 0.22-0.62),但非心血管死亡和全因死亡无显著关联。

要点

  • 移植后低磷血症常见且出现早,中位最低血磷1.58 mg/dl,发生于移植后33天。
  • 更严重低磷血症与较低的死亡删失移植失败和心血管死亡风险独立相关。
  • 低磷血症与全因死亡及非心血管死亡无显著关联。

核心结论

  • 移植后低磷血症出现早,并与有利的长期移植物和患者结局相关。

研究设计与样本

  • 单中心纵向队列研究,纳入957例1993至2008年间肾移植受者,随访中位9年(5-12年)。

主要发现

  • 中位最低血磷为1.58 mg/dl(IQR 1.30-1.95),达到时间为移植后33天(21-51天)。
  • 随访期间181例(19%)发生移植失败,295例(35%)死亡,其中94例(32%)为心血管死亡。
  • 完全校正后,血磷每降低1 mg/dl,死亡删失移植失败HR 0.61(95%CI 0.43-0.88),心血管死亡HR 0.37(95%CI 0.22-0.62)。
  • 非心血管死亡HR 1.33(95%CI 0.9-1.96),全因死亡HR 1.15(95%CI 0.81-1.61),均无显著关联。

关键数值与推荐

  • eGFR是最低血清磷水平的主要相关因素(模型R²=0.32)。

临床怎么用

  • 肾移植后第一年应关注血磷水平,低磷血症可能提示较好的长期移植结局。

局限性

  • 单中心回顾性队列设计,结果需外推验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Hypophosphatemia is common in the first year after kidney transplantation, but its clinical implications are unclear. We investigated the relationship between the severity of post-transplant hypophosphatemia and mortality or death-censored graft failure in a large cohort of renal transplant recipients with long-term follow-up. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a longitudinal cohort study in 957 renal transplant recipients who were transplanted between 1993 and 2008 at a single center. We used a large real-life dataset containing 28,178 phosphate measurements (median of 27; first to third quartiles, 23-34) serial measurements per patient) and selected the lowest intraindividual phosphate level during the first year after transplantation. The primary outcomes were all-cause mortality, cardiovascular mortality, and death-censored graft failure. RESULTS: The median (interquartile range) intraindividual lowest phosphate level was 1.58 (1.30-1.95) mg/dl, and it was reached at 33 (21-51) days post-transplant. eGFR was the main correlate of the lowest serum phosphate level (model R2 =0.32). During 9 (5-12) years of follow-up, 181 (19%) patients developed graft failure, and 295 (35%) patients died, of which 94 (32%) deaths were due to cardiovascular disease. In multivariable Cox regression analysis, more severe hypophosphatemia was associated with a lower risk of death-censored graft failure (fully adjusted hazard ratio, 0.61; 95% confidence interval, 0.43 to 0.88 per 1 mg/dl lower serum phosphate) and cardiovascular mortality (fully adjusted hazard ratio, 0.37; 95% confidence interval, 0.22 to 0.62) but not noncardiovascular mortality (fully adjusted hazard ratio, 1.33; 95% confidence interval, 0.9 to 1.96) or all-cause mortality (fully adjusted hazard ratio, 1.15; 95% confidence interval, 0.81 to 1.61). CONCLUSIONS: Post-transplant hypophosphatemia develops early after transplantation. These data connect post-transplant hypophosphatemia with favorable long-term graft and patient outcomes.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. van Londen M, Aarts BM, Deetman PE, et al. Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation. Clin J Am Soc Nephrol. 2017. PMID: 28546442. doi:10.2215/CJN.10270916

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。